Concepedia
Statistics
Publications
45
Citations
3.8K
H-Index
28
Active since
2006
Affiliations
Samsung Medical Center(Current)
Sungkyunkwan University
Samsung (South Korea)
Gyeongsang National University
Korea Advanced Institute of Science and Technology
Bo Mi Ku is an author at Samsung Medical Center specializing in oncology, medicine, and molecular oncology.
Publications per year
2006–2023
Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma
Nayoung Kim, Hong Kwan Kim, Kyungjong Lee et al. · Nature Communications · 2020 · 1.3K citations · Full text
Medicine, Cancer Biology, Oncology +17
Pembrolizumab for Patients With Refractory or Relapsed Thymic Epithelial Tumor: An Open-Label Phase II Trial
Jinhyun Cho, Hae Su Kim, Bo Mi Ku et al. · Journal of Clinical Oncology · 2018 · 343 citations · Full text
Medicine, Oncology, Pharmacotherapy +15
The First-week Proliferative Response of Peripheral Blood PD-1+CD8+ T Cells Predicts the Response to Anti-PD-1 Therapy in Solid Tumors
Kyung Hwan Kim, Jinhyun Cho, Bo Mi Ku et al. · Clinical Cancer Research · 2019 · 212 citations · Full text
Medicine, Oncology, Pharmacology +17
Caffeine-Mediated Inhibition of Calcium Release Channel Inositol 1,4,5-Trisphosphate Receptor Subtype 3 Blocks Glioblastoma Invasion and Extends Survival
Sang Soo Kang, Kyung‐Seok Han, Bo Mi Ku et al. · Cancer Research · 2010 · 186 citations · Full text
Life Sciences, Oncology, Pharmacology +17
CHI3L1 (YKL‐40) is expressed in human gliomas and regulates the invasion, growth and survival of glioma cells
Bo Mi Ku, Yeon Kyung Lee, Jinhyun Ryu et al. · International Journal of Cancer · 2010 · 119 citations · Full text
Medicine, Cancer Biology, Oncology +16
1–5 of 45